Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies

Retrovirology

Volumn 7, Issue , 2010, Pages

  Qiu, Xiaoxing ^a   Swanson, Priscilla ^a   Luk, Ka Cheung ^a   Tu, Bailin ^a   Villinger, Francois ^b   Das Gupta, Jaydip ^c   Silverman, Robert H ^c   Klein, Eric A ^c   Devare, Sushil ^a   Schochetman, Gerald ^a   Hackett Jr, John ^a  

^a ABBOTT LABORATORIES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; GLYCOPROTEIN GP 70; MEMBRANE PROTEIN; PROTEIN P15E; PROTEIN VP30; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN; DIAGNOSTIC AGENT; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; MALE; NONHUMAN; RETROVIRUS; RETROVIRUS INFECTION; RHESUS MONKEY; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; WESTERN BLOTTING; XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS; ANIMAL; BLOOD; DISEASE MODEL; EPIDEMIOLOGY; EVALUATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MACACA; METHODOLOGY; VIROLOGY;

GAMMARETROVIRUS; MACACA; MACACA MULATTA; MIRIDAE; PRIMATES; XENOTROPIC MURINE LEUKEMIA VIRUS;

ANIMALS; ANTIBODIES, VIRAL; DISEASE MODELS, ANIMAL; EPIDEMIOLOGIC STUDIES; FEMALE; GAMMARETROVIRUS; HUMANS; IMMUNOASSAY; MACACA MULATTA; MALE; RECOMBINANT PROTEINS; RETROVIRIDAE INFECTIONS; SENSITIVITY AND SPECIFICITY; VIRAL STRUCTURAL PROTEINS; VIROLOGY;

EID: 77955545135     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-7-68     Document Type: Article

References (34)

1. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, Malathi K, Magi-Galluzzi C, Tubbs RR, Ganem D, Silverman RH, DeRisi JL. Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2006, 2:e25. 10.1371/journal.ppat.0020025, 1434790, 16609730.
2. Dong B, Kim S, Hong S, Das Gupta J, Malathi K, Klein EA, Ganem D, Derisi JL, Chow SA, Silverman RH. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci USA 2007, 104:1655-1660. 10.1073/pnas.0610291104, 1776164, 17234809.
3. Kim S, Kim N, Dong B, Boren D, Lee SA, Das Gupta J, Gaughan C, Klein EA, Lee C, Silverman RH, Chow SA. Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer. J Virol 2008, 82:9964-9977. 10.1128/JVI.01299-08, 2566297, 18684813.
4. Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci USA 2009, 106:16351-16356. 10.1073/pnas.0906922106, 2739868, 19805305.
5. Arnold RS, Makarova NV, Osunkoya AO, Suppiah S, Scott TA, Johnson NA, Bhosle SM, Liotta D, Hunter E, Marshall FF, Ly H, Molinaro RJ, Blackwell JL, Petros JA. XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH. Urology 2010, 75:755-761. 10.1016/j.urology.2010.01.038, 20371060.
6. Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Silverman RH, Mikovits JA. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 2009, 326:585-589. 10.1126/science.1179052, 19815723.
7. Switzer WM, Jia H, Hohn O, Zheng HQ, Tang S, Shankar A, Bannert N, Simmons G, Hendry RM, Falkenberg VR, Reeves WC, Heneine W. Absence of evidence of Xenotropic Murine Leukemia Virus-related virus infection in persons with Chronic Fatigue Syndrome and healthy controls in the United States. Retrovirology 2010, 7:57. 10.1186/1742-4690-7-57, 2908559, 20594299.
8. Fischer N, Hellwinkel O, Schulz C, Chun FKH, Huland H, Aepfelbacher M, Schlomm T. Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J Clin Virol 2008, 43:277-283. 10.1016/j.jcv.2008.04.016, 18823818.
9. Hohn O, Krause H, Barbarotto P, Niederstadt L, Beimforde N, Denner J, Miller K, Kurth R, Bannert N. Lack of evidence for xenotropic murine leukemia virus-related virus (XMRV) in German prostate cancer patients. Retrovirology 2009, 6:92. 10.1186/1742-4690-6-92, 2770519, 19835577.
10. Erlwein O, Kaye S, McClure MO, Weber J, Wills G, Collier D, Wessely S, Cleare A. Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS One 2010, 5:e8519. 10.1371/journal.pone.0008519, 2795199, 20066031.
11. Groom HCT, Boucherit VC, Makinson K, Randal E, Baptista S, Hagan S, Gow JW, Mattes FM, Breuer J, Kerr JR, Stoye JP, Bishop KN. Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology 2010, 7:10. 10.1186/1742-4690-7-10, 2839973, 20156349.
12. van Kuppeveld FJM, de Jong AS, Lanke KH, Verhaegh GW, Melchers WJG, Swanink CMA, Bleijenberg G, Netea MG, Galama JMD, van der Meer JWM. Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. BMJ 2010, 340:c1018. 10.1136/bmj.c1018, 2829122, 20185493.
13. Rosenberg N, Jolicoeur P. Retroviral Pathogenesis. Retroviruses 1997, 475-585. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, Coffin JM, Hughes SH, Varmus HE.
14. Weiss RA. The discovery of endogenous retroviruses. Retrovirology 2006, 3:67. 10.1186/1742-4690-3-67, 1617120, 17018135.
15. Metzger MJ, Holguin CJ, Mendoza R, Miller AD. The prostate cancer- associated human retrovirus XMRV lacks direct transforming activity but can induce low rates of transformation in cultured cells. J Virol 2010, 84:1874-1880. 10.1128/JVI.01941-09, 2812358, 20007266.
16. Rodriguez JJ, Goff SP. Xenotropic murine leukemia virus-related virus establishes an efficient spreading infection and exhibits enhanced transcriptional activity in prostate carcinoma cells. J Virol 2010, 84:2556-2562. 10.1128/JVI.01969-09, 2820921, 20015990.
17. Stieler K, Schulz C, Lavanya M, Aepfelbacher M, Stocking C, Fischer N. Host range and cellular tropism of the human exogenous gammaretrovirus XMRV. Virology 2010, 399:23-30. 10.1016/j.virol.2009.12.028, 20110097.
18. Schlecht-Louf G, Renard M, Mangeney M, Letzelter C, Richaud A, Ducos B, Bouallaga I, Heidmann T. Retroviral infection in vivo requires an immune escape virulence factor encrypted in the envelope protein of oncoretroviruses. Proc Natl Acad Sci USA 2010, 107:3782-3787. 10.1073/pnas.0913122107, 2840525, 20142478.
19. Onlamoon N, Das Gupta J, Sharma P, Rogers K, Suppiah S, Rhea J, Molinaro R, Gaughan C, Dong B, Klein EA, Qiu X, Devare S, Schochetman G, Hackett J, Silverman RH, Villinger F. Infection, viral dissemination and immune responses of Rhesus macaques with the human gammaretrovirus XMRV. Proc Natl Acad Sci USA (submitted).
20. Fass D, Harrison SC, Kim PS. Retrovirus envelope domain at 1.7 Å resolution. Nature Structural Biology 1996, 3:465-469. 10.1038/nsb0596-465, 8612078.
21. Furuta RA, Miyazawa T, Sugiyama T, Kimura T, Hirayama F, Tani Y, Shibata H. The prevalence of xenotropic murine leukemia virus-related virus in healthy blood donors in Japan. Retroviruses Conference, Cold Spring Harbor, NY (May 18-23, 2009)
22. Ihle JN, Domotor JJ, Bengali KM. Characterization of the type and group specificities of the immune response in mice to murine leukemia viruses. J Virology 1976, 18:124-131. 515530, 176456.
23. Stephenson JR, Peters RL, Hino S, Donahoe RM, Long LK, Aaronson SA, Kelloff GJ. Natural immunity in mice to structural polypeptides of endogenous type C RNA viruses. J Virology 1976, 19:890-898. 354929, 184303.
24. Lee JC, Ihle JN, Huebner R. The humoral immune response of NIH Swiss and SWR/J mice to vaccination with formalinized AKR or Gross murine leukemia virus. Proc Natl Acad Sci USA 1977, 74:343-347. 10.1073/pnas.74.1.343, 393256, 189311.
25. Cornetta K, Moen RC, Culver K, Morgan RA, McLachlin JR, Sturm S, Selegue J, London W, Blaese RM, Anderson WF. Amphotropic murine leukemia retrovirus is not an acute pathogen for primates. Human Gene Therapy 1990, 1:15-30. 10.1089/hum.1990.1.1-15, 1964393.
26. Barin F, McLane MF, Allan JS, Lee TH, Groopman JE, Essex M. Virus envelope protein of HTLV-Ill represents major target antigen for antibodies in AIDS patients. Science 1985, 228:1094-1096. 10.1126/science.2986291, 2986291.
27. Manns A, Murphy EL, Wilks R, Haynes G, Figueroa JP, Hanchard B, Barnett M, Drummond J, Waters D, Cerney M, Seals JR, Alexander SS, Lee H, Blattner WA. Detection of early human T-cell lymphotropic virus type I antibody Patterns during seroconversion among transfusion recipients. Blood 1991, 77:896-905.
28. Franchini G, Robert-Guroff M, Aldovini A, Kan NC, Wong-Staal F. Spectrum of natural antibodies against five HTLV-III antigens in infected individuals: correlation of antibody prevalence with clinical status. Blood 1987, 69:437-441.
29. Allain JP, Paul DA, Laurian Y, Senn D, . Members of the AIDS-Haemophilia French Study Group Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs. Lancet 1986, 328:1233-1236. Members of the AIDS-Haemophilia French Study Group.
30. Ly TD, Martin L, Daghfal D, Sandridge A, West D, Bristow R, Chalouas L, Qiu X, Lou SC, Hunt JC, Schochetman G, Devare SG. Seven human immunodeficiency virus (HIV) antigen-antibody combination assays: evaluation of HIV seroconversion sensitivity and subtype detection. J Clin Microbiol 2001, 39:3122-3128. 10.1128/JCM.39.9.3122-3128.2001, 88307, 11526139.
31. Qiu X, Hodges S, Lukaszewska T, Hino S, Arai H, Yamaguchi J, Swanson P, Schochetman G, Devare SG. Evaluation of a new, fully automated immunoassay for detection of HTLV-I and HTLV-II antibodies. J Med Virol 2008, 80:484-493. 10.1002/jmv.21083, 18205214.
32. Andersson S, Thorstensson R, Ramirez KG, Krook A, von Sydow M, Dias F, Biberfeld G. Comparative evaluation of 14 immunoassays for detection of antibodies to the human T-lymphotropic virus types I and II using panels of sera from Sweden and West Africa. Transfusion 1999, 39:845-851. 10.1046/j.1537-2995.1999.39080845.x, 10504120.
33. Thorstensson R, Andersson S, Lindbäck S, Dias F, Mhalu F, Gaines H, Biberfeld G. Evaluation of 14 commercial HIV-1/HIV-2 antibody assays using serum panels of different geographical origin and clinical stage including a unique seroconversion panel. J Virol Methods 1998, 70:139-151. 10.1016/S0166-0934(97)00176-6, 9562408.
34. McGinn TM, Wei Q, Stallworth J, Fultz PN. Immune responses to HTLV-I (ACH) during acute infection of pig-tailed macaques. AIDS Res Human Retroviruses 2004, 20:443-456.